
Bortrac 2 Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Bortezomib (2mg)
Overview Bortrac 2 Injection
Oncotrac injection is indicated for managing multiple myeloma and mantle cell lymphoma. Its mechanism involves inhibiting or retarding cancerous cell proliferation. Administration is exclusively via injection by a healthcare professional. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Adhere strictly to the prescribed regimen; incorrect usage or overdose can lead to severe adverse events. Therapeutic effects may not be immediately apparent; discontinue only under medical supervision. Common side effects include tiredness, nausea, vomiting, and anorexia. Increased fluid intake is often recommended. Operating machinery or driving should be avoided due to potential drowsiness and dizziness. This medication can suppress blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests are crucial to monitor blood cell levels, along with cardiac, hepatic, and uric acid levels. Pre-treatment consultation is essential if you have pre-existing liver, kidney, or heart conditions, or a bleeding disorder. Report cognitive changes such as memory impairment or difficulty concentrating to your doctor. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception is vital for both partners throughout treatment to prevent pregnancy.
Uses of Bortrac 2 Injection
Myeloma and mantle cell lymphoma
Major Benefits of Bortrac 2 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Bortrac 2 Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Bortrac 2 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Bortrac 2 Injection works:
Bortrac 2 Injection is an anticancer agent that inhibits the cellular degradation of proteins. This accumulation of proteins within cancer cells ultimately triggers their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Bortrac 2 Injection and alcohol may lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Bortrac 2 Injection during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Bortrac 2 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from the medication.
DrivingUNSAFE
Administering Bortrac 2 Injection may induce adverse reactions that impair driving capabilities. These reactions can include fatigue, vertigo, syncope, or visual disturbances, all potentially impacting the ability to operate a vehicle safely.
KidneyCAUTION
Administering Bortrac 2 Injection to individuals with advanced renal impairment requires careful consideration. Dosage modification for Bortrac 2 Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should use Bortrac 2 Injection judiciously. Dosage modification of Bortrac 2 Injection may be necessary. Physician consultation is advised.
What if you forget to take Bortrac 2 Injection :
Should you forget a scheduled Bortrac 2 Injection, seek advice from your physician.
Facts to Know About Bortrac 2 Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylalanine-based Compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
